Search results
Results from the WOW.Com Content Network
The lack of a warning sent Bristol Myers' shares up 6.3% at $53.28 in premarket trading on Friday. Bristol Myers obtained drug Cobenfy, also known as KarXT, through its $14 billion takeover of ...
Xanomeline/trospium chloride, sold under the brand name Cobenfy, is a fixed-dose combination medication used for the treatment of schizophrenia. [1] It contains xanomeline , a muscarinic agonist ; and trospium chloride , a muscarinic antagonist . [ 1 ]
Bristol-Myers won't make any investor into a millionaire overnight. Its market cap is upwards of $118 billion, and in 2023 its top line was worth $45 billion, with net income of nearly $8 billion.
As a result of this significant underperformance, Bristol-Myers Squibb's stock trades at just 8 times forward earnings at current levels, well below the S&P 500's multiple of 21.5.
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey , [ 2 ] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb_Company&oldid=971830359"
Image source: The Motley Fool. Bristol Myers Squibb (NYSE: BMY) Q3 2024 Earnings Call Oct 31, 2024, 8:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants
Get answers to your AOL Mail, login, Desktop Gold, AOL app, password and subscription questions. Find the support options to contact customer care by email, chat, or phone number.